NeuExcell Therapeutics Inc. logo

NeuExcell Therapeutics Inc.

4 Marks
First Filed:Oct 22, 2021Latest Filed:Mar 4, 2024Address:401 N. Broad St., Suite 242, Philadelphia, PA 19108

Portfolio Overview

Registered
2(50%)
Pending
1(25%)
Dead
1(25%)

Top Classes

Class 5
Pharmaceuticals
2(50%)
Class 42
Software, IT Services & Scientific Research
2(50%)

TTAB Proceedings

No litigation activity

Top Firms

Sunstein LLP(Mar 2024)
4

Trademark Portfolio

4 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
NEUEXCELL
NEUEXCELL
Service Mark
Word
REGISTERED
Owner:
Serial:98432310
Filed:Mar 4, 2024
Classes:42
Registration:8119752
Registered:Jan 27, 2026
Goods & Services
Research and development of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), Huntington's disease, epilepsy, physical injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, infection, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemic or hemorrhagic myelopathy (myelopathy), global ischemia, hypoxic ischemic encephalopathy, embolism, fibrocartilage embolism myelopathy, thrombosis, nephropathy, chronic inflammatory disease, meningitis, cerebral venous sinus thrombosis, retinal disease and other disease arising from neuronal damage; and testing, inspection, research or development of pharmaceutical preparations for gene therapy or small molecule treatment
ATN
ATN
Trademark
Word
ABANDONED
Owner:
Serial:97227543
Filed:Jan 19, 2022
Classes:5
ATN ASTROCYTES TO NEURONS
REGISTERED
Owner:
Serial:97227503
Filed:Jan 19, 2022
Classes:42
Registration:8033032
Registered:Nov 18, 2025
Goods & Services
"ASTROCYTES TO NEURONS"; Research and development of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), Huntington's disease, epilepsy, physical injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, infection, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemic or hemorrhagic myelopathy (myelopathy), global ischemia, hypoxic ischemic encephalopathy, embolism, fibrocartilage embolism myelopathy, thrombosis, nephropathy, chronic inflammatory disease, meningitis, cerebral venous sinus thrombosis, retinal disease and other disease arising from neuronal damage; and testing, inspection, research or development of pharmaceutical preparations for gene therapy or small molecule treatment
NEUEXCELL
NEUEXCELL
Trademark
Word
ITU
PENDING
Owner:
Serial:97087345
Filed:Oct 22, 2021
Classes:5
Goods & Services
Pharmaceuticals for treating Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis (ALS), Huntington's Disease, epilepsy, spinal cord injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, viral and baterial infections, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemic or hemorrhagic myelopathy (myelopathy), global ischemia, hypoxic ischemic encephalopathy, embolism, fibrocartilage embolism myelopathy, thrombosis, nephropathy, chronic inflammatory disease, meningitis, and cerebral venous sinus thrombosis

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.